title: Attenuation of age- and sucrose-induced insulin resistance and syndrome X by a synergistic antioxidant cocktail: the AMIS syndrome and HISS hypothesis.
abstract: Absence of meal-induced insulin sensitization (AMIS) results in a predictable progression of dysfunctions, including postprandial hyperglycemia, compensatory hyperinsulinemia, resultant hyperlipidemia, increased oxidative stress, and obesity, progressing to syndrome X and diabetes. To one year of age, rats show a slow development of AMIS, but this can be potentiated by addition of a low-dose sucrose supplement to the diet. Provision of a synergistic antioxidant cocktail consisting of S-adenosylmethionine, vitamin E, and vitamin C (Samec) attenuates the rate and extent of development of AMIS in both normal aging animals and in aging animals on the sucrose diet. Adiposity, assessed from weighed regional fat masses and from bioelectrical impedance to estimate whole-body adiposity, correlated strongly with AMIS (r2 = 0.7-0.8). Rats given the sucrose supplement had accelerated AMIS and developed fasting hyperinsulinemia and postprandial hyperglycemia, hyperlipidemia, hyperinsulinemia, and adiposity. Samec completely compensated for the negative impact of this sucrose supplement and attenuated development of the associated dysfunctions. AMIS is explained by the HISS (hepatic insulin-sensitizing substance) hypothesis, which is outlined in the paper.
authors.affiliation: Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Manitoba, 753 McDermot Avenue, Winnipeg, MB R3E 0T6, Canada. wlautt@cc.umanitoba.ca
authors.forename: W Wayne
authors.initials: WW
authors.lastname: Lautt
authors.forename: Zhi
authors.initials: Z
authors.lastname: Ming
authors.forename: Dallas J
authors.initials: DJ
authors.lastname: Legare
mesh_terms: D000375:Aging / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage*; D001685:Biological Factors / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology / Q000378:metabolism* / Q000503:physiopathology; D004357:Drug Synergism; D004435:Eating / Q000502:physiology*; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D008099:Liver / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D024821:Metabolic Syndrome / Q000209:etiology / Q000378:metabolism* / Q000503:physiopathology; D011237:Predictive Value of Tests; D051381:Rats; D013395:Sucrose / Q000008:administration & dosage*
chemical_list: D000975:Antioxidants; D001685:Biological Factors; D013395:Sucrose
references.citation: Int J Clin Pract Suppl. 2003 Mar;(134):18-27
references.pmid: 12793594
references.citation: J Gerontol. 1956 Jul;11(3):298-300
references.pmid: 13332224
references.citation: Obes Res. 2004 Aug;12(8):1352-9
references.pmid: 15340119
references.citation: Invest Ophthalmol Vis Sci. 2007 Feb;48(2):479-85
references.pmid: 17251439
references.citation: Blood Coagul Fibrinolysis. 2007 Jun;18(4):353-9
references.pmid: 17473577
references.citation: Am J Physiol. 1996 Aug;271(2 Pt 1):E246-52
references.pmid: 8770017
references.citation: Can J Physiol Pharmacol. 1998 Dec;76(12):1080-6
references.pmid: 10326829
references.citation: J Comp Neurol. 2001 Jun 4;434(3):358-77
references.pmid: 11331534
references.citation: Nature. 2006 Apr 13;440(7086):944-8
references.pmid: 16612386
references.citation: Am J Physiol. 1996 May;270(5 Pt 1):E858-63
references.pmid: 8967475
references.citation: J Biochem. 1974 Jan;75(1):93-103
references.pmid: 4151174
references.citation: Aust N Z J Med. 1990 Aug;20(4):570-7
references.pmid: 2222350
references.citation: Diabetologia. 2005 May;48(5):976-83
references.pmid: 15830187
references.citation: Proc West Pharmacol Soc. 1998;41:37-8
references.pmid: 9836234
references.citation: Am J Physiol Gastrointest Liver Physiol. 2001 Jul;281(1):G29-36
references.pmid: 11408252
references.citation: Br J Nutr. 2000 Mar;83 Suppl 1:S71-7
references.pmid: 10889795
references.citation: Exp Physiol. 2007 Nov;92(6):1005-13
references.pmid: 17644704
references.citation: Diabetes Metab Res Rev. 2001 Jan-Feb;17(1):19-26
references.pmid: 11241888
references.citation: Exp Gerontol. 2008 Aug;43(8):790-800
references.pmid: 18538970
references.citation: J Gerontol A Biol Sci Med Sci. 2008 Jun;63(6):560-5
references.pmid: 18559629
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2005 Jul;372(1):71-8
references.pmid: 16059734
references.citation: Br J Pharmacol. 2006 Apr;147(8):959-65
references.pmid: 16491098
references.citation: Physiol Rev. 1979 Jul;59(3):527-605
references.pmid: 37532
references.citation: Can J Physiol Pharmacol. 2008 Dec;86(12):880-8
references.pmid: 19088809
references.citation: Can J Physiol Pharmacol. 2009 Oct;87(10):873-82
references.pmid: 20052013
references.citation: Br J Nutr. 2006 Feb;95(2):288-95
references.pmid: 16469144
references.citation: Obesity (Silver Spring). 2007 Jul;15(7):1685-93
references.pmid: 17636086
references.citation: Nature. 2001 Dec 13;414(6865):813-20
references.pmid: 11742414
references.citation: Free Radic Biol Med. 2000 Aug;29(3-4):222-30
references.pmid: 11035250
references.citation: J Cardiovasc Pharmacol. 1992;20 Suppl 8:S26-8
references.pmid: 1283766
references.citation: Ther Clin Risk Manag. 2007 Oct;3(5):761-70
references.pmid: 18473001
references.citation: Obes Res. 2005 Apr;13(4):717-28
references.pmid: 15897481
references.citation: Am J Physiol Gastrointest Liver Physiol. 2003 Apr;284(4):G588-94
references.pmid: 12466146
references.citation: J Gerontol. 1983 Nov;38(6):673-7
references.pmid: 6630900
references.citation: Gen Pharmacol. 1980;11(4):343-5
references.pmid: 6995222
references.citation: Diabetes. 1990 Nov;39(11):1420-4
references.pmid: 2227114
references.citation: Exp Eye Res. 2005 Oct;81(4):478-91
references.pmid: 15935343
references.citation: Am J Physiol. 1999 Jul;277(1):G101-8
references.pmid: 10409156
references.citation: Obes Res. 2001 Aug;9(8):423-31
references.pmid: 11500522
references.citation: Biochem J. 2004 Aug 15;382(Pt 1):131-6
references.pmid: 15142037
references.citation: Diabetes. 1997 Oct;46(10):1579-85
references.pmid: 9313753
references.citation: FASEB J. 2006 Apr;20(6):631-7
references.pmid: 16581971
references.citation: Biochem J. 1988 Nov 15;256(1):205-12
references.pmid: 2851978
references.citation: Essays Biochem. 2006;42:75-88
references.pmid: 17144881
references.citation: Endocrinol Metab Clin North Am. 1995 Jun;24(2):255-72
references.pmid: 7656891
references.citation: Am J Physiol Endocrinol Metab. 2002 Feb;282(2):E286-96
references.pmid: 11788359
references.citation: FASEB J. 1999 Jun;13(9):1055-64
references.pmid: 10336888
references.citation: Can J Physiol Pharmacol. 2002 Jan;80(1):8-12
references.pmid: 11911229
references.citation: Auton Neurosci. 2007 Oct 30;136(1-2):1-19
references.pmid: 17537681
references.citation: Can J Physiol Pharmacol. 1999 Aug;77(8):553-62
references.pmid: 10543718
references.citation: Obesity (Silver Spring). 2007 Feb;15(2):314-21
references.pmid: 17299103
references.citation: Can J Appl Physiol. 2004 Dec;29(6):808-29
references.pmid: 15630152
references.citation: Am J Cardiol. 2007 Aug 1;100(3):524-7
references.pmid: 17659940
references.citation: Free Radic Biol Med. 2006 Feb 15;40(4):617-24
references.pmid: 16458192
references.citation: Metabolism. 2002 May;51(5):544-8
references.pmid: 11979383
references.citation: Br Heart J. 1986 Apr;55(4):348-54
references.pmid: 3964501
references.citation: J Auton Pharmacol. 1995 Oct;15(5):361-9
references.pmid: 8744976
references.citation: Circulation. 2005 Oct 25;112(17):2735-52
references.pmid: 16157765
references.citation: Med Res Rev. 2003 Jan;23(1):1-14
references.pmid: 12424750
references.citation: Prog Clin Biol Res. 1989;304:259-75
references.pmid: 2675032
references.citation: J Pharmacol Sci. 2004 May;95(1):9-17
references.pmid: 15153645
references.citation: J Cardiometab Syndr. 2006 Fall;1(5):362-3
references.pmid: 17679794
references.citation: Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3474-8
references.pmid: 16877418